S&P 500 Healthcare Sector SEC Filings — April 28, 2026

28-04-2026

Maravai LifeSciences Holdings, Inc. (MRVI) filed a DEFA14A proxy statement detailing its board structure, reduced from 11 to 8 directors since the 2025 annual meeting, with Class III directors (Bernd Brust, Gregory T. Lucier, Luke Marker) up for election to serve until 2029. The filing outlines deadlines for 2027 Annual Meeting shareholder proposals (December 25, 2026 for Rule 14a-8 inclusion) and nominations (by close of business February 25, 2027). It also describes the Director Nomination Agreement providing GTCR entities with board nomination rights scaled to ownership levels (e.g., 100% if >=40% of IPO ownership).

• ·Shareholder proposals under Rule 14a-8 for 2027 AGM inclusion must be received no later than December 25, 2026.
• ·Director nomination notices (not for proxy inclusion) due by close of business February 25, 2027 (not earlier than January 26, 2027).
• ·Universal proxy rule notice for competing nominees due by March 27, 2027.
• ·Ratification of Deloitte & Touche LLP as auditor for year ending December 31, 2026 is a routine matter allowing broker discretionary voting.
• ·Ages of directors as of March 27, 2026: Bernd Brust (59), Gregory T. Lucier (61), Luke Marker (41), Susannah Gray (65), R. Andrew Eckert (64), Constantine Mihas (59), Sean Cunningham (50), John DeFord (64).

28-04-2026

KB Financial Group Inc. filed its Form 20-F Annual Report on April 28, 2026, providing a table of contents covering financial information, market risks, controls, and additional disclosures. The report highlights restrictions on subsidiary dividends under the Korean Commercial Code and Bank Act, including a requirement to allocate at least 10% of net profit to a legal reserve until it equals paid-in capital, and potential Financial Services Commission restrictions if capital adequacy ratios are not met. Other disclosures include merchant fees charged to members ranging from 0.4% to 2.3% with discounts for small- and medium-sized enterprises, and exclusions of proceeds from non-performing loan sales.

• ·Dividends payable only from distributable income calculated as net assets minus paid-in capital, mandatory legal reserves, and certain unrealized profits as of prior fiscal period end.
• ·Financial Services Commission may restrict bank dividends if capital adequacy ratio not met or under management improvement measures.
• ·Merchant fees include maintenance, prepayment costs, processing, delinquency management, loan loss provisions, and fixed costs.
• ·Excludes proceeds from sales of non-performing loans that were written off.

28-04-2026

Stewards, Inc. disclosed executive compensation for 2025 showing significant increases in total pay primarily due to $1,000,000 RSU grants to each named executive officer, with Vincent Napolitano's total rising 103% YoY to $1,913,432 and Shaun Quin's up 192% to $1,562,430; however, base salaries declined for some like Napolitano (from $233,610 to $205,432). The company approved a new executive compensation program with STI/LTI elements, stock ownership guidelines, and clawbacks, alongside a leadership transition where Vincent Napolitano steps to Chairman Emeritus, Glen Steward to Chairman, and Shaun Quin to CEO. Directors will receive $30,000 annual cash retainers plus $135,000 in RSUs under a new policy effective Q4 2025.

• ·Glen Steward resigned as Chief Strategy Officer effective Dec 1, 2025, but remains on Board.
• ·No compensation expense recognized for 2025 RSUs as vesting not probable at Dec 31, 2025.
• ·RSU vesting requires uplisting to Nasdaq, S-8 effectiveness, and service period.
• ·Incentive Plan effective Aug 21, 2024, terminates Aug 21, 2034 unless earlier.
• ·New comp program phased 2025-2028; ownership guidelines 6x salary for CEO, etc.
• ·Board majority-independent post-Napolitano transition per Nasdaq Rule 5605.

28-04-2026

Controladora Vuela Compania de Aviacion, S.A.B. de C.V. (Volaris) discloses 100% equity ownership in five Mexican trusts (Banco Multiva Fidecomisos CIB/3853, 3855, 3866, 3867, 3921) for financing pre-delivery payments under its Airbus aircraft purchase agreement, with Banco Multiva assuming rights from CIBanco effective September 2, 2025. The company also reports 100% ownership in Fidecomiso CIB/3249, through which subsidiary Volaris Opco issued three series of asset-backed securities notes (15 million units each): VOLARCB 19 (Ps.1.5B or $78.5M, fully amortized June 20, 2024), VOLARCB 21L (Ps.1.5B or $72.1M), and VOLARCB 23 (Ps.1.5B or $85.8M), under CNBV-approved programs up to Ps.3.0B ($157.1M/$144.2M) and Ps.5.0B ($286.2M). Two additional 100%-owned administrative trusts (F/745291 and CIB/3081) manage shares.

• ·VOLARCB 19 notes fully amortized on June 20, 2024.
• ·Banco Multiva assumed all rights and obligations of CIBanco effective September 2, 2025.

28-04-2026

Farnam Financial LLC, an Arizona-based investment manager, filed its 13F-HR on April 28, 2026, disclosing $121,517,718 in total holdings across 49 positions as of March 31, 2026. The portfolio is dominated by ETFs, with top holdings including Vanguard Total Stock Market ETF ($11,626,314, 36,240 shares), iShares 0-3 Month Treasury ($10,631,707, 105,620 shares), and Schwab U.S. Large-Cap ETF ($9,355,838, 364,892 shares). Individual stocks such as Apple ($4,848,165, 19,103 shares), Intel ($2,887,291, 65,427 shares), and Berkshire Hathaway ($2,846,927, 5,941 shares) represent smaller allocations.

• ·All positions reported with sole discretionary voting power (OTR 0 0).
• ·Business address: 4539 N 22nd St Ste N, Phoenix, AZ 85016.
• ·SEC file number: 028-25707.

28-04-2026

Centene Corporation reported strong Q1 2026 financial results with premium and service revenues up 5% YoY to $44,655 million, adjusted diluted EPS of $3.37 exceeding expectations by $0.50, HBR improving to 87.3% from 87.5%, and SG&A ratio declining to 7.6% from 7.9%, alongside $1.0 billion debt reduction and $4,366 million operating cash flow. However, total at-risk membership fell 6% YoY to 26,272,900, driven by sharp Commercial declines (Marketplace down 36% to 3,582,200) and Medicaid reductions to 12,426,900. The company raised FY2026 adjusted diluted EPS guidance to greater than $3.40 and premium revenues to $171.0-$175.0 billion.

• ·Centene named one of the World's Most Admired Companies by Fortune for eighth consecutive year.
• ·FY2026 guidance: Total revenues $187.5-$191.5 billion; HBR 90.9%-91.7%; Adjusted SG&A 7.0%-7.6%.
• ·Conference call scheduled for April 28, 2026 at 8:30 a.m. ET.
• ·Days in claims payable (DCP) at 48 days, up 2 days from Q4 2025.

28-04-2026

ASA Gold & Precious Metals Limited is in the process of selling a portion of its position in a privately held portfolio company through multiple transactions at different prices, with each transaction recognized upon closing. If consummated at anticipated prices, this could result in an approximate 2-3% increase in net asset value. However, there is no assurance that any transactions will complete or at the expected prices.

• ·Filing discloses information under Item 7.01, furnished not filed, not subject to Section 18 liability or incorporation by reference.
• ·Common Shares trade as ASA on NYSE, par value $1.00 per share.

28-04-2026

News Corporation filed an 8-K disclosing information provided to the Australian Securities Exchange (ASX) regarding its ongoing stock repurchase program, which authorizes up to $1 billion in aggregate for Class A and Class B common stock. The disclosures are attached as Exhibits 99.1 and 99.2, with forward-looking statements on intent to repurchase shares from time to time, subject to market conditions and other factors.

• ·Filing pertains to Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
• ·Class A Common Stock (NWSA) and Class B Common Stock (NWS) traded on Nasdaq Global Select Market.
• ·Date of earliest event reported: April 27, 2026; Filing Date: April 28, 2026.

28-04-2026

Exencial Wealth Advisors, LLC, based in Oklahoma City, OK, filed a 13F-HR reporting total holdings of $3,217,468,970 across 568 positions as of March 31, 2026. Top holdings include Apple Inc. at $114,288,462 (450,327 shares), Dimensional ETF Trust US Small Cap Val at $98,019,900 (2,797,372 shares), and Invesco Exchange Traded FD T S&P500 EQL WGT at $79,667,694 (415,109 shares). No period-over-period comparisons or performance changes are detailed in the filing.

• ·Filing date: April 28, 2026
• ·Report period end: March 31, 2026
• ·SEC file number: 028-15490
• ·Former company name: Burns Wealth Management, Inc. (name change date: May 7, 2013)

28-04-2026

Revolution Medicines, Inc. has filed a DEFA14A proxy statement soliciting proxies for its Annual Meeting of Stockholders scheduled for June 18, 2026, at 7:30 a.m. PDT, held virtually at www.virtualshareholdermeeting.com/RVMD2026. Stockholders are appointing Mark A. Goldsmith, M.D., Ph.D. and Jeffrey Cislini, or either of them, as proxies to vote shares in accordance with Board recommendations if no directions are provided.

• ·Proxy voting available at www.proxyvote.com
• ·Meeting accessible at www.virtualshareholdermeeting.com/RVMD2026

28-04-2026

Johnson & Johnson's 2026 Annual Meeting of Shareholders occurred on April 23, 2026, where all 12 director nominees were elected with strong support (over 1.65 billion shares For each). Shareholders approved the advisory vote on executive compensation and ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026. However, the shareholder proposal requiring an independent board chair was rejected, with only 406,353,048 shares For versus 1,326,857,173 Against.

• ·Say-on-pay advisory vote: 1,641,173,032 For, 91,774,923 Against, 9,607,174 Abstained.
• ·Auditor ratification: 1,914,846,474 For, 138,633,899 Against, 3,481,479 Abstained (no non-votes).
• ·Director elections showed some opposition, e.g., J. Duato: 1,654,870,358 For, 84,725,734 Against.
• ·Filing signed April 27, 2026, by Marc Larkins.

28-04-2026

CCEP reported Q1 2026 revenue of €5,001 million, up 6.7% as reported and 9.4% comparable FX-neutral from €4,689 million in Q1 2025, supported by strong 8.5% volume growth to 970 million unit cases and higher average daily sales. Europe revenue rose 9.1% to €3,549 million with 1.3% revenue per unit case growth, while APS revenue increased modestly 1.1% to €1,452 million but revenue per unit case declined 0.3%. Overall revenue per unit case grew 0.8% to €5.29 amid 93 consumption days versus 87 prior year.

• ·FX impact on total revenue: +€131 million
• ·FX impact on Europe revenue: +€24 million
• ·FX impact on APS revenue: +€107 million
• ·Total average daily sales: 10.43 million unit cases (Q1 2026) vs 10.27 (Q1 2025), +1.6%

28-04-2026

For Q1 2026, Bread Financial Holdings, Inc. reported net income of $181 million, up 32% YoY from $138 million, with net interest income rising 6% to $1,067 million and non-interest expenses declining 1% to $472 million. Earnings per diluted common share surged 50% to $4.15, supported by credit sales growth of 7% to $6,510 million and improved credit metrics including a lower delinquency rate of 5.59%. However, non-interest income worsened to $(49) million from $(36) million due to higher interchange revenue losses, and provision for credit losses increased 2% to $303 million.

• ·Net interest margin improved to 19.25% from 18.06%.
• ·Return on average tangible common equity rose to 27.4% from 23.0%.
• ·End-of-period credit card and other loans increased 2% to $18,135M.
• ·Common equity tier 1 capital ratio strengthened to 13.3% from 12.0%.
• ·Net principal loss rate improved to 7.33% from 8.16%.
• ·Cash from operating activities increased to $487M from $393M.

28-04-2026

Security National Financial Corporation (SNFCA) filed a DEFA14A Definitive Additional Proxy Materials on April 28, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee is required and is submitted by the registrant. No substantive proxy details or financial data are provided in the document.

• ·Filing Type: DEFA14A
• ·Subcategory: Proxy Statement
• ·Filed by Registrant (checked)
• ·No fee required

28-04-2026

BeOne Medicines Ltd. (BEIGF) has filed a DEFA14A proxy statement for its 2026 Annual General Meeting on June 11, 2026, in Zürich, Switzerland, to approve FY2025 Swiss statutory financial statements, board re-elections and new director elections, auditor ratifications, executive and board compensation, equity incentive plans, and share issuance (20%) and repurchase (10%) mandates. The Board recommends voting FOR all 20 proposals, including special allocations to maintain Amgen Inc.'s shareholding percentage. Proxy materials, including the FY2025 Form 10-K, are available online at https://ir.beonemedicines.com/filings-financials/shareholder-meeting-materials.

• ·Record date for attendance and voting: May 22, 2026
• ·Proxy materials request deadline: June 1, 2026
• ·Independent Voting Representative: Schweiger Advokatur/Notariat, Dammstrasse 19, 6300 Zug, Switzerland
• ·Meeting time: 3:30 p.m. local time

28-04-2026

Ellington Financial Inc. issued a press release on April 27, 2026, announcing its estimated book value per share of common stock as of March 31, 2026, furnished under Item 7.01 to satisfy Regulation FD requirements. The press release is attached as Exhibit 99.1. No specific book value figure or period-over-period comparisons are provided in the filing.

• ·Filing signed on April 27, 2026.
• ·Principal executive offices: 53 Forest Avenue, Old Greenwich, CT 06870; Telephone: (203) 698-1200.
• ·Securities traded on The New York Stock Exchange.

28-04-2026

Sagimet Biosciences Inc. (SGMT) entered into an Underwriting Agreement dated April 27, 2026, with Leerink Partners LLC, TD Securities (USA) LLC, and Guggenheim Securities, LLC for the issuance and sale of Common Stock in a public offering, as disclosed in this 8-K filing under Items 1.01 and 9.01. A legal opinion from Goodwin Procter LLP confirming the legality of the offering is attached as Exhibit 5.1, with the company's consent included therein. The report was signed by CEO David Happel on April 28, 2026.

28-04-2026

Wave Life Sciences reported Q1 2026 financial results with revenue of $38.2 million, up significantly from $9.2 million in Q1 2025, and a reduced net loss of $26.1 million compared to $46.9 million prior year, supported by a strong cash position of $544.6 million providing runway into 3Q 2028. However, cash decreased from $602.1 million at year-end 2025, R&D expenses rose to $47.4 million from $40.6 million, and G&A expenses increased to $22.1 million from $18.4 million YoY. Pipeline progress includes FDA acceptance for Phase 2a INLIGHT trial of WVE-007 initiating in 2Q 2026, data presentations for WVE-006 at ATS in May 2026, and upcoming milestones for WVE-008 and WVE-N531.

• ·Phase 2a INLIGHT trial accepted by FDA for individuals with BMI 35-50 kg/m2, on track to initiate 2Q 2026.
• ·Data from RestorAATion-2 400 mg monthly and 600 mg single dose cohorts to be presented at ATS investor webcast May 18, 2026.
• ·Regulatory feedback on accelerated approval for WVE-006 expected mid-2026.
• ·CTA for WVE-008 on track for 2026; NDA for WVE-N531 on track for 2026.
• ·Phase 1 INLIGHT additional data from 600 mg SAD cohort expected 2026.

28-04-2026

GM Financial reported first quarter 2026 net income of $514 million, up 3% YoY from $499 million and 12% QoQ from $460 million. However, total originations declined 15% YoY to $12.3 billion, with retail loan originations down 14% to $8.3 billion and operating lease originations down 19% to $4.0 billion; delinquencies also rose with 31-60 days at 2.4% (vs 2.2% YoY) and over 60 days at 0.9% (vs 0.7% YoY). Earning assets totaled $123.9 billion at quarter-end, supported by available liquidity of $35.0 billion.

• ·Allowance for loan losses as % of retail finance receivables: 3.6% at Mar 31, 2026 (up from 3.5% at Dec 31, 2025)
• ·Commercial finance receivables: $15.7B at Mar 31, 2026 (down from $16.9B at Mar 31, 2025)
• ·Revenue: $4,276M in Q1 2026 (up from $4,164M in Q1 2025)
• ·Provision for loan losses: $267M in Q1 2026 (down from $328M in Q1 2025)

28-04-2026

Norwood Financial Corp, the holding company for Wayne Bank, filed an 8-K on April 28, 2026, disclosing a slideshow presentation to be used at its 2026 Annual Meeting of Stockholders. The presentation covers the Company's financial performance and business strategies and is furnished as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure). No specific financial metrics or period-over-period comparisons were detailed in the filing itself.

• ·Filing includes Exhibit 99.1: Annual Meeting Presentation dated April 28, 2026
• ·Securities: Common Stock, $0.10 par value (NWFL) listed on The Nasdaq Stock Market

28-04-2026

First Commonwealth Financial Corporation (NYSE: FCF) reported Q1 2026 GAAP net income of $37.5 million ($0.37 diluted EPS), down $7.3 million or 16% QoQ from $44.9 million ($0.43 EPS) but up $4.9 million or 15% YoY from $32.7 million ($0.32 EPS). While average deposits grew $67.1 million (2.7% annualized QoQ), NIM expanded 30 bps YoY to 3.92%, and the board approved a 3.7% dividend increase to $0.14 per share, end-of-period loans fell $74.2 million (3.2% annualized QoQ), provision expense rose $3.7 million QoQ to $10.7 million, and core efficiency ratio worsened 259 bps QoQ to 55.43%. The company repurchased 1,284,457 shares at $17.67 average price, with strong capital ratios including Bank-level Total Capital at 13.8%.

• ·Loan-to-deposit ratio decreased 447 bps to 90.9% in Q1 2026.
• ·Tangible book value per share increased $0.12 (4.3% annualized QoQ).
• ·AOCI as % of tangible common equity increased 30 bps to 5.90%.
• ·Company capital ratios: Total 14.9%, Tier I 13.2%, Leverage 10.9%, CET1 12.5% at March 31 2026.
• ·Subsequent to quarter-end, two nonaccrual commercial credits totaling $5.6M (with $3.3M reserves) sold or paid off.

28-04-2026

First Financial Corporation reported Q1 2026 net income of $19.8 million, up 7.6% YoY from $18.4 million, with diluted EPS of $1.67 versus $1.55, record net interest income of $56.9 million (+9.5% YoY), and total loans reaching $4.42 billion (+14.79% YoY), supported by the March 1 acquisition of CedarStone Financial adding $292 million in loans and $313 million in deposits. However, average total deposits grew only 0.28% YoY to $4.66 billion, provision for credit losses increased to $2.6 million from $2.0 million, nonperforming loans rose to $28.5 million (0.64% of loans versus 0.26%), and non-interest expense climbed to $40.9 million from $36.8 million, pushing the efficiency ratio to 58.72% from 57.54%. The net interest margin expanded to 4.23% from 4.11%, while credit quality showed stable allowance coverage but higher delinquencies.

• ·Net charge-offs decreased to $1.5 million in Q1 2026 from $1.8 million YoY.
• ·Bargain purchase gain of $716 thousand from CedarStone acquisition.
• ·Quarterly dividend of $0.56 per share paid in January 2026 and April 15, 2026.
• ·Tangible book value per share increased 18.36% YoY to $45.13.

28-04-2026

AEW Capital Management LP filed a 13F-HR combination report disclosing $1,377,962,295 in total holdings across 78 securities as of March 31, 2026, predominantly in real estate investment trusts (REITs) managed jointly with Natixis Advisors, LLC and Russell Investments Group, Ltd. Top positions include Welltower Inc ($129.5M, 655,123 shares), Prologis Inc. ($81.0M, 612,947 shares), Simon Property Group Inc ($44.8M, 240,244 shares), Realty Income Corp ($39.1M, 639,128 shares), and VICI Properties Inc ($36.9M, 1,350,008 shares). The filing provides a current snapshot of U.S. equity positions with no period-over-period changes detailed.

• ·Holdings span REIT sub-sectors including healthcare (e.g., Welltower $129.5M), industrial (e.g., Prologis $81.0M), retail (e.g., Simon $44.8M), gaming (VICI $36.9M), and apartments (e.g., AvalonBay $58.4M).
• ·Smaller positions include Lineage Inc (550 shares, $18,018), Tanger Inc (1,862 shares, $63,271), and Stag Industrial Inc (1,552 shares, $55,965).
• ·Report filed April 28, 2026, for quarter ended March 31, 2026.

28-04-2026

Disciplined Equity Management, Inc. filed its 13F-HR report on April 28, 2026, disclosing total equity holdings of $199003990 across 44 positions as of March 31, 2026. The portfolio is dominated by Dimensional ETF Trust funds totaling approximately $152 million, with the largest position in Dimensional ETF Trust US Mktwide Value (808704 shares, $39189796). Notable individual stock holdings include Dow Hldgs Inc (82799 shares, $3448579), Altria Group Inc (37545 shares, $2477595), and Conagra Brands Inc (132670 shares, $2085573); no prior period comparisons or changes are provided.

• ·Report period end date: March 31, 2026
• ·Filing CIK: 0001909380
• ·Business address: 200 1st Street Suite 204, Neptune Beach, FL 32266
• ·Business phone: 904-222-0280

28-04-2026

Principal Exchange-Traded Funds sent a reminder letter dated May 4, 2026, to shareholders of the Principal Capital Appreciation Select ETF urging them to vote at the Special Meeting on June 25, 2026, to approve changing the Fund's sub-classification from 'diversified' to 'non-diversified' under the Investment Company Act of 1940 and updating the related fundamental investment restriction. The Board of Trustees recommends voting FOR, highlighting benefits like enhanced investment flexibility and alignment with market developments, with no material change to the investment strategy or services provided to shareholders.

• ·Proxy solicitor: Sodali Fund Solutions (SFS) at 1-888-569-8137
• ·Vote by phone: 1-888-569-8137 (weekdays 10 a.m. to 11 p.m. ET)
• ·Link to materials: https://proxyvotinginfo.com/p/prinetf

28-04-2026

The Federal Home Loan Bank of Cincinnati filed an 8-K on April 28, 2026, reporting new Consolidated Bonds issued with trade dates April 22-24, 2026, for which it is the primary obligor, with par values totaling $3,867,000,000 across 14 tranches. These bonds feature maturities ranging from December 2026 to May 2041, coupon rates from 3.870% to 5.400%, and various call types including Optional Principal Redemption and Non-Callable. The filing notes this is routine funding via capital markets, with no judgment on materiality of individual issuances.

• ·Consolidated Obligations are joint and several obligations of the 11 Federal Home Loan Banks, backed only by their financial resources, not guaranteed by the U.S. government.
• ·Schedule A excludes Consolidated Discount Notes due to short-term maturities (max 360 days) and does not reflect interest-rate exchange agreements or derivatives.
• ·Par amounts on Schedule A are at par and may differ from GAAP financial statement amounts due to discounts, premiums, or concessions.

28-04-2026

Share Andrew L. filed a 13F-HR on April 28, 2026, disclosing institutional holdings as of March 31, 2026, with a total portfolio value of $214337227 across 16 positions, all held solely. The largest holding is EQT Corp valued at $121585175 (1910515 shares), followed by UBS Select Govt Instl Fd at $70082808 and Net Power Inc Cl A at $15237300 (9767500 shares). Other notable positions include Comstock Resources Inc ($2740400, 130000 shares) and Net Power Inc Warrant ($1442488, 5342547 warrants).

• ·All 16 holdings have sole voting and disposition power (SH SOLE)
• ·Report period end date: 2026-03-31
• ·Filing SEC file number: 028-17579
• ·Contact: Dennis Kushmerek, Boston MA, phone 617-345-6136

28-04-2026

Univest Financial Corp reported net income of $27,092 thousand for Q1 2026, up 21% YoY from $22,395 thousand, with diluted EPS rising to $0.96 from $0.77 amid 12% YoY growth in net interest income to $63,365 thousand and lower interest expense. Noninterest income increased 8% YoY to $24,088 thousand. However, total deposits declined 4% QoQ to $6,813,763 thousand from $7,087,313 thousand, total assets fell 3% QoQ to $8,141,582 thousand, and cash equivalents dropped sharply 60% QoQ to $222,357 thousand.

• ·Provision for credit losses declined 44% YoY to $1,303 thousand from $2,311 thousand.
• ·Noninterest expense rose 7% YoY to $52,669 thousand, driven by higher salaries and restructuring charges of $427 thousand.
• ·Weighted-average basic shares outstanding decreased to 28,033 thousand from 29,001 thousand YoY.

28-04-2026

Baxter Bros Inc filed its Form 13F-HR on April 28, 2026, disclosing 166 equity positions held as of March 31, 2026, with total portfolio value implied by individual holdings exceeding $1 billion across US stocks, ADRs, and ETFs. Top holdings include Microsoft Corp ($48.1M), Exxon Mobil Corp ($46.3M), Alphabet Inc Cl C ($33.7M), and Visa Inc ($28.5M), all with sole voting power. No prior period comparisons or changes are detailed in this snapshot filing.

• ·All 166 positions held with sole voting power (SH SOLE).
• ·Business address: 1030 East Putnam Ave, Riverside, CT 06878.
• ·Phone: 203-637-4559.
• ·Fiscal year end: December 31.
• ·SEC file number: 028-05169.

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026